ArticleFrontiers in immunology2024

Total eosinophil count as a biomarker for therapeutic effects of upadacitinib in atopic dermatitis over 48 weeks.

Teppei Hagino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.